Twin Transitions by Aksan, Anna-Maria & Chakraborty, Shankha
MPRA
Munich Personal RePEc Archive
Twin Transitions
Anna-Maria Aksan and Shankha Chakraborty
Fairfield University, University of Oregon
27. May 2013
Online at http://mpra.ub.uni-muenchen.de/49929/
MPRA Paper No. 49929, posted 23. September 2013 06:56 UTC
Twin Transitions
Anna-Maria Aksan
Fairfield University
aaksan@fairfield.edu
Shankha Chakraborty
University of Oregon
shankhac@uoregon.edu
May 2013
Abstract
We provide a new explanation for sub-Saharan Africa’s slow demographic and
economic change. In a model where children die from infectious disease, child-
hood health affects human capital and noninfectious-disease-related adult mor-
tality. When child mortality falls from lower prevalence, as in western Europe, la-
bor productivity improves, fertility falls and the economy prospers. When it falls
mainly from better cures, as in sub-Saharan Africa, survivors are less healthy and
there is little economic payoff. The model quantitatively explains sub-Saharan
Africa’s experience. More generally it shows that life expectancy at birth is a poor
indicator of population health unless morbidity falls with mortality.
KEYWORDS: Demographic Transition, Epidemiological Transition, Mortality, Mor-
bidity, Fertility
JEL CLASSIFICATION: I10, I12, J13, O40
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1 Introduction
A leading view of the demographic transition links the fertility transition to prior reduc-
tions of child mortality. This pattern fits well several early industrializers of the nine-
teenth century and many developing countries in the twentieth century. Sub-Saharan
Africa has been an exception to the pattern: despite significant improvement in child
mortality, its fertility transition has been markedly slower than what we have come to
expect from completed transitions elsewhere.
We argue that the health of Africa’s population has improved much less than im-
provements in child mortality or life expectancy at birth would suggest and that is why
its fertility transition has been slower and yielded little economic benefit. Our explana-
tion draws on the link between the demographic and epidemiological transitions. Dur-
ing the latter, infectious disease mortality among the young and elderly falls, followed
by non-infectious diseasemortality among older adults. Falling infectious diseasemor-
tality is typically associated with falling morbidity as younger adults become healthier
and fewer older adults suffer from non-infectious disease. This link between mortality
and morbidity has weakened for sub-Saharan Africa (SSA).
In this paper, we develop a general equilibrium dynastic model that qualitatively
andquantitatively accounts for SSA’s demographic anddisease transitions. In themodel,
infectious disease affects susceptible children some of whom die. The health of sur-
viving children is weakened, lowering the return on their human capital investment.
Childhood infections also predispose people towards non-communicable illnesses like
cardiovascular disease (CVD) later in life. The attendant childhoodmorbidity and adult
mortality affect the value parents place on family size relative to child quality and their
own future needs.
We differentiate between two ways child mortality can decline, from lower infec-
tious disease prevalence or better therapy that attenuates infections.1 Falling preva-
lence was behind the West’s mortality transition and morbidity declined in tandem.
For example, child survival gains in late nineteenth century England and Wales were
followed by secular gains in adult stature in successive cohorts. African countries, on
the other hand, have reduced childmortality through better treatments like antibiotics.
While vaccination has eradicated diseases like smallpox and polio, those have been the
1This distinction is made for conceptual clarity. While some therapeutic treatments can lower preva-
lence by reducing contagion, that effect is typically second-order. See also footnote 12.
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exceptions. This means decades of falling child mortality have not substantially low-
ered the prevalence of many major infectious diseases in SSA. Unlike other developing
regions, adult stature and non-infectious diseasemortality have improved little even as
nutrition steadily improved.
In the model when child mortality falls from lower prevalence, more surviving chil-
dren are of better quality (health), which raises the return to investing in their educa-
tion. Altruistic parents substitute toward child quality. The total and net fertility rates
fall. Since fewer children suffer from infections in early life, as adults they face a lower
risk of premature death from CVDs. This further lowers the fertility rate and raises in-
vestment in physical capital. These forces facilitate epidemiological, demographic and
economic transitions.
When child mortality falls from better cures, having suffered through repeated in-
fections more surviving children are of worse quality. Parents have little incentive to
invest in their human capital and continue to choose relatively large families. While
the total fertility rate falls, net fertility may not. Moreover, due to infections in early
life, a large share of the adult population is exposed to CVD-related premature mortal-
ity. Here themortality transition does not translate into a fertility or an epidemiological
transition. Economic growth may even worsen if the morbidity effect is particularly se-
vere. A calibrated version of the model mimics the mortality transition in SSA versus
the historical experience of England & Wales. We show that the morbidity channel can
plausibly explain the recent African experience and that child mortality alone can be a
poor predictor of national health and development.
Our paper builds on the economic demography literature. Using CRRA preferences
and ignoring child survival uncertainty, Doepke (2005) points to a puzzle: improving
child survival lowers the total fertility rate but leaves net fertility unaffected, unlike his-
torical demographic transitions. Evenwith these two assumptions net fertility responds
to child mortality in our model because child quality is heterogeneous and healthy and
unhealthy children are imperfect substitutes for parents.
Four papers in the health and demography literature are particularly relevant to this
work.2 Strulik (2008) attributes stalled demographic transitions in the tropics to dis-
eases. In his model the shadow cost of a child is higher in low-disease environments
2The epidemiological transition receives no attention in this literature except forMorand (2002). Since
Morand’s model does not account for the shifting disease pattern observed during the transition nor its
effect on fertility and child quality, it is more appropriately viewed as a health transition that enhances
overall quality of life.
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similar to us, but the mechanism is different: parental investment in nutrition is as-
sumed to be less effective at improving child survival in low-disease environments. In
Birchenall (2007), the decline of infectious disease drives the transition to modern eco-
nomic growth. He too distinguishes between infection and case fatality rates but the
transition occurs through parental investment in nutrition. This paper is closely re-
lated to, and complements, de la Croix and Licandro (2012) who propose that rising life
expectancy and sustained physical development made possible western Europe’s fer-
tility transition. Besides providing a micro-foundation for this mechanism, we empha-
size the scarring effect of childhoodmorbidity. This furthers our understanding of how
Europe’s epidemiological transition was vital to its demographic and economic tran-
sitions and especially why similar dividends have not followed from Africa’s rising life
expectancy before theHIV crisis. By linking the demographic and epidemiological tran-
sitions, we also show how the same weak response explains Africa’s higher incidence of
adult mortality and morbidity.
Our earlier work, Aksan and Chakraborty (2013), is the first to connect the nature
of sub-Saharan Africa’s mortality transition to its slow fertility transition. The scope of
that paper is more limited. It develops a partial equilibrium model of fertility choice
under uncertain child survival and tests for its predictions using data on malaria, HIV,
diarrheal and lower respiratory infections. While we ignore uncertainty in this paper,
we capture a broader canvas. By explicitly formalizing the general equilibrium effects
of Africa’s mortality transition on fertility, epidemiology, adult mortality, morbidity and
human capital, we are able to quantitatively assess how well transition paths explain
Africa’s population and economic changes.
Child mortality, life expectancy at birth and adult mortality have been variously
linked to fertility behavior, human capital investment and growth in the literature. Con-
versely some newer papers, notably Acemoglu and Johnson (2007), question if the rela-
tionship between life expectancy at birth and economic development is strong or even
positive. Our work cautions against the use of mortality alone to gauge the relationship
between population health and economic development.
The rest of this paper is organized as follows. Section 2 presents a set of stylized facts
on the demographic and epidemiological transitions and health. Section 3 constructs
a dynastic model whose implications are developed in Sections 4 and 5. Quantitative
experiments in Section 6 highlight the cost of childhoodmorbidity and the ability of the
theory to explain SSA’s experience.
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2 Some Facts
We begin with some facts on the demographic and epidemiological transitions. Eng-
land & Wales is taken to represent the historical transition since we have reliable time
series data on mortality, fertility and cause of death going back to the mid-nineteenth
century.
2.1 The Demographic Transition
The conventional view of the demographic transition posits that falling child mortality
makes possible subsequent fertility declines. This is the pattern exhibited by early in-
dustrializers such as England, Germany and Sweden where fertility responded to mor-
tality with a lag. Figure 1 illustrates the case of England & Wales: the sharp decline in
child mortality that began around 1872 was followed about five years later by declines
in the total and net fertility rates.3 While this pattern may not fit all transitions in the
nineteenth century (Galor, 2005), it does in the twentieth century: falling child mortal-
ity has been instrumental in worldwide fertility reductions during 1955°2005 (Angeles,
2010).
Despite large declines in childmortality sub-SaharanAfrica’s (SSA) fertility has, how-
ever, not fallen as rapidly as we have come to expect from successful transitions (Figure
2). For example, while the child mortality rate (CMR) in Niger fell from 319.4 per 1,000
live births (1966) to 168.5 (2005), its total fertility rate (TFR) increased from 7.26 to 7.3.
Uganda’s CMR fell from 202.6 per 1,000 live births (1965) to 115.5 (2005), while its TFR
declined slightly from 7.1 to 6.6. The elasticity of TFR response with respect to CMR
since the 1960s is lowest for SSA, 0.48 versus 0.71° 0.81 for other developing regions
(World Bank). This response is also weaker compared to England & Wales. While CMR
fell by similar magnitudes during the first forty years of transition, 46% in SSA (1965-
2005) and 45% in England & Wales (1870-1910), SSA’s TFR declined by 21% compared
to 37% in the latter.
3Infant mortality did not start falling until the early 1900s. A succession of hot summers in the late
nineteenth and early twentieth centuries reduced the availability of clean water, causing diarrhea out-
breaks. It has been conjectured that infant mortality would have otherwise fallen earlier (Hinde, 2003).
For comparability, we restrict ourselves to child mortality rates in both the UK and SSA.
5
2.2 The Epidemiological Transition
The onset of the epidemiological transition – the shift in mortality and disease patterns
identified by Omran (1971) – makes possible the demographic transition. Declining in-
fectious disease mortality among children and the elderly is followed by declining non-
infectious disease death, primarily from CVDs, among the middle-aged and elderly.
Figure 3 shows how the transition unfolded in England&Wales: infectious diseasemor-
tality started falling around 1872 and non-infectious disease mortality followed after
about twenty years (Arora, 2005).4
Here too the experience of SSA differs fundamentally. Figure 4 compares infectious
disease deaths for children and non-infectious disease deaths for the elderly between
SSA and England & Wales. Statistics for the latter are reported at three levels of life
expectancy at birth. English life expectancy of 53 during 1905°14 comes closest to the
current life expectancy of 42°63 in SSA. Using that number as a crude age-standardized
measure, the infectious disease burden in the two regions looks comparable. The non-
infectious disease burden, on the other hand, is more than four times higher in SSA.
Underlying this is the earlier age at which CVD deaths have been occurring there. The
Global Burden of Disease project (2004) reports that CVD deaths accounted for 30% of
all non-HIV-related deaths among 30°69 year olds in SSA, about four times that in the
US (Leeder et al., 2003).
This difference is picked up by data on adult mortality. During the past seventy
years, life expectancy at birth has converged around the world due to improvements in
child survival in developing countries (Soares, 2007). In contrast, the adult survival rate
or its complement, the probability of dying between the ages of 15 and 60 (45q15), shows
no such tendency. Figure 5 shows this non-convergence is driven by Africa’s persistently
high adult mortality pre-dating the HIV crisis.
2.3 ChildhoodMorbidity
One way to assess childhoodmorbidity is to look at adult stature, the cumulative prod-
uct of childhood nutrition net of various claims on it including infections. The decline
4Death rates are age-standardized. The epidemiological transition is usually stated in terms of in-
creasing incidence of noninfectious disease deaths as infectious disease mortality falls. This is certainly
true of England & Wales: the share of all disease-caused deaths due to noninfectious disease rose over
time. Arora’s work shows that this is because people were living longer and that, more importantly, non-
infectious disease mortality rates among the middle-aged and elderly fell.
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of infectious diseasemortality in England&Wales was followed about fifteen years later
by height gains in successive cohorts of 18-year old males (Figure 6). These gains oc-
curred as childhood diseasemorbidity fell along withmortality (Bozzoli et al., 2009; see
also Voth and Leunig, 1996).5
Compared to this clear pattern, DHS survey data presented in Figure 7 shows that
cohorts of African women enjoying better childhood survival did not experience pro-
nounced height gains. In fact, after modest gains, average height has fallen in SSA since
1960. In principle this reflects the combined effect of childhood nutrition and disease
exposure. Since nutrition in the first five years of life are crucial for physical develop-
ment, we report 5-yearmoving averages of daily calorie intake (FAO) in Figure 7. Except
for the late eighties, nutrition generally improved since 1960.6
Calorie supply data may, of course, not identify disruptions in food supply, for ex-
ample due to civil wars. Moradi (2006) finds that the latter explains little of the decline
in stature. Likewise Africa’s debt crisis and structural adjustment programs can at best
explain the decline in the late 1980s. Even there the evidence is unclear. Real pub-
lic health expenditures generally rose or remained steady during structural adjustment
due to increased World Bank adjustment lending. User fees instituted in some coun-
tries as part of the reforms were irregularly enforced, often accounting for a small per-
centage of national budgets. Where reformsmay have had some impact was in shifting
health care priorities from preventive to curative strategies (Sahn and Bernier, 1995),
consistent with our theory.
Two clarifications are in order. First, the trends that emerge from Figure 7 are un-
likely to be driven by country composition. The nutrition data covers the same 44 coun-
tries throughout these years. We do havemissing observations for CMR during 1960-75
(23 countries with data in 1960, 29 in 1965, 38 in 1970, 42 in 1975, 44 1980 onwards).
The height data is not available for all countries, but it is available for over 30 countries,
including 8 of the 10 most populous countries of sub-Saharan Africa. Exact country
composition of height data for a particular year changes, but the countries that have
height data have it for several decades. Akachi and Canning’s (2010) more systematic
5The sharp fall in the decades preceding 1850 in Figure 6 has been linked to urbanization and a series
of epidemics. It preceded the secular decline of child mortality. In fact it was the catalyst for aggressive
public health initiatives that made possible the subsequent mortality transition (Szreter,1988). Nine-
teenth century height gains were not unique to England (de la Croix and Licandro, 2012).
6Figure 7 data are 1985 population weighted. Dropping Nigeria, which accounts for close to a quar-
ter of SSA’s population, takes the correlation between height and nutrition from 0.02 to a still weak 0.2.
Protein intake shows similar improvements over the years.
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analysis of the data affirm the overall trend of Figure 7.
Secondly, selection is unlikely to explain Figure 7. If innately strong children survive
to adulthood when CMR is very high, recent declines in stature throughout SSA may
reflect a weakening of this selection effect. Yet this would have been also true in earlier
transitions. As seen by a clear increase in adult stature following mortality declines,
morbidity must have declined enough in Europe to dominate any such selection effect.
We conclude that Figure 7 strongly indicates Africa’s childhood disease exposure
slowed physical improvements initially, possibly reversing them later, despite continu-
ing improvements in childhood survival.
2.4 Child Quality
Next consider evidence on the long-term effects of childhood health. Awell-established
body of research links adult height to higher earning in developing countries and birth-
weight to higher adult schooling attainment, height and earnings. More recently, Case
and Paxson (2010) find that taller individuals attain higher levels of education and that
height is positively associated with better economic, health, and cognitive outcomes,
associations only partly explainedby the higher average educational attainment of taller
individuals. Almond’s (2006) study of the effect of the 1918 influenza epidemic on co-
horts born in and around that time finds adverse lifetime socioeconomic and physical
effects.
Frequent infections prevent the absorption of nutrients necessary for optimal cel-
lular growth, affecting children’s physical and cognitive development (Martorell and
Habicht, 1986). The literature on the effect of specific infections on children is vast.
We highlight a few papers that inform our modeling assumptions. Anemia is the most
common type of malarial morbidity, estimated to be 75% in areas where prevalence
exceeds 25%. It is associated with poor school performance and lower earnings among
working adults (Snow et al., 2003; see Bleakley, 2007, for evidence on hookworm-related
anemia and Bleakley and Lange, 2009, for its effect on fertility). Malarial infections are
blamed for a 14-24% birthweight shortfall among slaves (Coelho andMcGuire, 2000), a
1.1 inch height gap amongUnion Army veterans (Hong, 2007) and lower education and
worse cognitive functions in the Taiwanese population (Chang et al., 2011).
After malaria, diarrheal infections are the next highest cause of child mortality in
Africa. Many children survive them but infections are frequent, averaging 9 median
8
episodes during the first 4 years (Boschi-Pinto et al., 2006). Checkley et al. (2008) report
that the possibility of stunting at 24 months of age increases multiplicatively with each
diarrheal episode. More direct evidence comes from Guerrant et al. (2003): diarrhea in
the first 2 years of life is strongly associated with impaired cognitive function 4°7 years
later among Brazilian children even when disease symptoms did not manifest.
2.5 Late-Life Mortality
Childhood infections also increase susceptibility to non-infectious disease later in life.
Measles, typhoid andmalaria during childhood are known to be associatedwith cardio-
vascular problems, and pneumonia before age five to diminished respiratory function
at ages 59-70 (Khosla, 1981, Barker 1994). Males who were in utero during the Spanish
flu epidemic of 1918 had a 23% higher rate of heart disease in their 60°80s regardless
of whether or not their mothers had visible flu symptoms (Mazumder et al., 2010). Peo-
ple who experienced higher malaria exposure risk in Taiwan had a higher incidence of
CVDs and a higher mortality hazard in old age (Chang et al., 2011).
In England, France, Sweden and Switzerland, improved longevity in the elderly, as
indicated by declines in CVD, occurred among the same birth cohorts that experienced
mortality reduction at younger ages. These cohorts were taller than their predecessors
(Crimmins and Finch, 2006). Declining childhood and young adult infectious disease
rates amongUnion Army veterans accounted for nearly 50% of the higher survival rates
among 50–64 year oldmales (Costa, 2003). Jousilahti et al.’s (2000) study of Finnishmen
and women offers another set of evidence linking childhood health to late-life mortal-
ity: height is inversely associated with CVD and total mortality, controlling for other
known risk factors. This link between infectious and non-infectious disease is evident
in Figure 3: non-infectious disease mortality followed infectious disease mortality by
about a generation during the English epidemiological transition.
3 TheModel
Our theory accounts for these facts by distinguishing between two ways child mortal-
ity can be lowered: lower disease prevalence (reduced exposure) or lower case fatality
rate from an infection (better therapy). We argue that better therapy played a vital role
in SSA’s child mortality declines while historical declines, including England & Wales’,
9
occurred due to the conquest of infectious diseases.7
Themodel economy is comprised of an infinite sequence of three-period lived over-
lapping generations of families. Not everyone lives for all three periods as some chil-
dren die before reaching adulthood and some older adults die prematurely. Individu-
als are socially and economically active only in youth and old age. As active decision
makers, young parents care about their own consumption and the number and human
capital of their surviving children. Besides working, they allocate their time to raising
surviving children and educating them.
Some children die in their early childhood from infectious disease. Define the sur-
vival rate of infected children by p ¥ 1°d where d is the average case fatality rate from
infections, that is, the mortality rate conditional on contracting infections. If i denotes
the average childhood infection rate, then the (unconditional) childmortality rate is id .
While the fatality rate is taken to be exogenously given by the state ofmedical knowhow
and health care, the infection rate will be later determined endogenously.
We assume all children are homogeneous in health at birth. Of the nt children born
to each young adult in period t , (1° it )nt children are healthy (denoted by h), never
having contracted infectious diseases. Another pitnt children are unhealthy (denoted
by u), having experienced but survived from chronic infections. The total number of
surviving children is then (1° it )nt +pitnt = (1°dit )nt .
3.1 Households and Preferences
A parent invests education time eht 2 [0,1] and eut 2 [0,1] towards each type of surviving
child. The time cost of rearing an unhealthy child could be different from that of a
healthy child. For example, if an unhealthy child needsmore care due to frequent bouts
of infection and related health problems, it is reasonable to assume øu > øh .
Parents base their decisions on the expected number of survivors of each type. A
7Since developing countries have all benefited from cures invented in theWest, this also explains why
the TFR response to CMR in other developing regions, while higher than SSA’s, has been generally weaker
than England & Wales’. That adult stature improved and adult mortality fell indicates that morbidity fell
sufficiently with mortality in these regions unlike SSA (details available upon request).
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young parent with human capital xt maximizes expected lifetime utility8
Ut = lnctt+Ø¡t lnctt+1+∞µ ln[(1°dit )nt ]+∞(1°µ)
∑
1° it
1°dit lnx
h
t+1+
pit
1°dit lnx
u
t+1
∏
(1)
by choosing {ctt ,c
t
t+1,nt ,e
h
t ,e
u
t } subject to the constraints
ctt =
h
1°
n
(1° it )(øh +eht )+pit (øu +eut )
o
nt ° st
i
zt (2)
ctt+1 =
Rt+1
¡t
st zt (3)
xht+1 = ∏("+qheht )∫x∑t x¯1°∑t , eht ∏ 0 (4)
xut+1 = ∏("+queut )∫x∑t x¯1°∑t , eut ∏ 0 (5)
and taking the vector (¡t , it ,wt ,Rt+1) as given. Here Ø 2 (0,1) is a subjective discount
rate, ¡t 2 (0,1] is the probability of surviving through old age and µ 2 (0,1) is parental
valuation of child quantity versus quality. There are decreasing returns to quality in-
vestment ∫ 2 (0,1), the productivity parameter ∏ is positive and " > 0 ensures positive
human capital in the absence of quality investment. Wage per unit of human capital is
represented by w while s denotes the propensity to save out of “full income” z ¥ wx.
The second budget constraint incorporates the assumption of perfect annuities.
The last term in the utility function is a joy-of-giving bequest motive; (1° i )/(1°di )
is the fraction of surviving children who are healthy, pi/(1°di ) the fraction who are
unhealthy.9 Embedded in it is an important assumption: healthy and unhealthy chil-
dren are imperfect substitutes. This assumption is central to generating the appropriate
fertility and investment responses when child mortality falls.
The last two constraints in the parent’s decision problem specify the human capi-
tal production function for each type of surviving child. Besides parental investment
and human capital, they depend on the average human capital across working adults,
x¯, when ∑ 2 (0,1). The return to investment in child quality depends on health human
capital q j , j 2 {h,u}, which is the outcome of a child’s disease experience. Specifically
it takes the value qh = 1 should the child have experienced no (significant or recurrent)
infectious disease and qu = ± 2 (0,1) otherwise. That illness from infectious disease de-
8Utility from premature death in old age is being normalized to a large negative number and param-
eter values are implicitly assumed to ensure old age consumption remains sufficiently above zero. That
adults do not die from CVDs in their working life is a simplification.
9For i = 0 this term simplifies to lnxh , for i = 1 to lnxu . Hence (1) nests the commonly used quantity-
quality specification for homogeneous child quality, ∞ [µ lnn+ (1°µ) lnx].
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preciates intrinsic health and cognitive abilities through ± is relevant only when quality
investment is positive.
3.2 Old AgeMortality
Old age non-infectious diseases affect survival when people are retired and consume
out of accumulated wealth. The survival probability depends on childhood health. The
evidence presented in section 2.5 shows infectious diseases in childhood to be an im-
portant determinant of cardiovascular diseases and ill health for older adults. We as-
sume that an individual who was exposed to infectious diseases as a child in period
t but survived faces a lower survival probability ¡u < 1 in period t + 2. Otherwise his
probability of survival is ¡h >¡u . Hence
¡t =
(
¡u , if It°2 = 1
¡h , if It°2 = 0
(6)
where It°2 is an indicator function that takes the value 1 if the person was infected as a
child in t °2 and zero otherwise.
3.3 Production of Final Output
Let X denote the aggregate stock of human capital andK the aggregate stock of physical
capital. Production of final output Y occurs according to the technology
Yt = AK Æt X 1°Æt (7)
where A > 0 andÆ 2 (0,1). Output and inputsmarkets are perfectly competitive and the
depreciation rate on physical capital is hundred percent.
3.4 Optimization
We start with household decisions. Denote the average cost per childbirth by
¬t ¥ (1° it )(øh +eht )+pit (øu +eut ) (8)
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Substituting the production function for human capital into (1) and ignoring additive
constant terms, the decision problem becomes one of maximizing
Max{st ,nt ,eht ,eut } ln
£°
1°¬tnt ° st
¢
zt
§+Ø¡t ln[st zt ]+∞µ ln[(1°dit )nt ]
+∫∞(1°µ)
∑
1° it
1°dit ln("+e
h
t )+
pit
1°dit ln("+±e
u
t )
∏
subject to eht , e
u
t ∏ 0. Inada conditions guarantee that inequality constraints for con-
sumption in the two periods are satisfied. Besides the interior equilibrium, two types of
corner equilibria are possible: eut = eht = 0 and eut = 0, eht > 0. As long as the average cost
per childbirth is low, which occurs for relatively high prevalence rates, parents choose
large families over investing in child quality.10
Interior equilibrium
In an interior equilibrium for quality investment, investment in unhealthy children is
lower the higher is the morbidity effect of infections (lower ±)
eut = eht °
µ
1°±
±
∂
". (9)
In turn this implies their human capital is a ± proportion of that of healthy children,
xut+1 = ±∫xht+1. Using (9), we express the average cost of fertility as
¬t = øt + (1°dit )eht °¥it (10)
where øt ¥ (1° it )øh + pitøu is the average cost of child quantity and ¥ ¥ (1°±)"p/±
the quality cost saving from investing in unhealthy children relative to healthier ones.
It follows that
st = Ø¡t1+∞µ+Ø¡t , nt =
∞µ
1+∞µ+Ø¡t
µ
1
¬t
∂
,
10Here parents do not take any action to lower their children’s exposure to infections. Since infectious
disease transmission depends strongly on a negative externality, for high enough prevalence rates, par-
ents would optimally choose not to invest in prevention (Chakraborty et al., 2010). We focus on macro-
level prevention when discussing the health transition. Prevention at the household level would rein-
force the benefits of these macro-policies. Without the latter, prevention incentives at the household
level would be lacking and hence, on their own, cannot facilitate the transition.
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and that quality investment in healthy children is
eht =
∫(1°µ)
µ°∫(1°µ)
∑
øt °¥it
1°dit °
"µ
∫(1°µ)
∏
.
For the latter to be economically meaningful requires that
∫< µ/(1°µ) and "< ∫(1°µ)øh/µ. (A1)
The first restriction is guaranteed if µ > 1/2, similar to other models of fertility. The
second one ensures that maximal human capital investment in healthy children is pos-
itive.
Collecting these results, equilibriumexpressions for the average cost of childbearing
and human capital are
¬t = µ
µ°∫(1°µ)
£
øt °¥it ° (1°dit )"
§
xht+1 = ∏x∑t x¯1°∑t
∑
∫(1°µ)
µ°∫(1°µ)
∏∫∑øt °¥it
1°dit °"
∏∫
xut+1 = ±∫xht+1.
Note that quality investments are decreasing in the prevalence rate if√(it )¥ (øt°¥it )/(1°
dit ) is. This requires p(øu °øh)°¥< 0, or,
øu < øh +
µ
1°±
±
∂
". (A2)
In other words, unhealthy children cannot be too costly. Else parental time saved from
having healthier children would be directed towards raising more children instead of
quality investment.
Corner equilibrium
Besides (A1) positive quality investment in healthy children requires that
°h(it )¥√(it )° µ"
∫(1°µ) ∏ 0.
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Likewise eut ∏ 0 requires that
°u(it )¥√(it )° µ"
∫(1°µ) °
µ°∫(1°µ)
∫(1°µ)
µ
1°±
±
∂
"∏ 0.
Evidently °h ∏ °u while (A2) ensures that√ is decreasing in it . Let the threshold preva-
lence rates i h and i u < i h be defined implicitly by °h(i h)= 0 and °u(i u)= 0.
For it 2 (i u , i h), °h > 0 but °u < 0. Here parents invest in healthy children but not
in unhealthy ones: eht > 0, eut = 0. While the saving propensity st is the same as in the
interior equilibrium, other decisions change. Using the new expression for the average
cost per childbirth, ¬t = øt + (1° it )eht , we obtain
eht =
∫(1°µ)
µ°∫(1°µ)
≥
1°it
1°dit
¥ ∑ øt
1°dit °
"µ
∫(1°µ)
∏
, nt = ∞µ1+∞µ+Ø¡t
µ
1
¬t
∂
.
For it > i h , on the other hand, °h < 0 and parents do not invest in either healthy or
unhealthy children, eut = eht = 0. The saving decision is unchanged but since the average
cost is lower still at ¬t = øt , fertility is the highest in this corner equilibrium
nt = ∞µ1+∞µ+Ø¡t
µ
1
¬t
∂
.
The Effect of Mortality
Relevant to the demographic transition are how quantity and quality of children re-
spond to child mortality. The latter depends on the prevalence rate it and the case
fatality rate d , both of which are exogenous to a parent’s decisions.
Since the fertility rate nt does not depend on household characteristics, specifically
xt , it corresponds to the total fertility rate (TFR) and responds negatively to fertility
cost ¬t . Consider first interior quality equilibria where ¬t is a decreasing function of
both it and d by assumption (A2). Here a decrease in child mortality either through the
prevalence or case fatality rate lowers the TFR, consistent with the facts outlined earlier.
For the demographic transition, though, what is relevant is the expected number of
surviving children, nˆt = (1°dit )nt , or the net fertility rate (NFR). This is given by
nˆt = ∞[µ°∫(1°µ)]1+∞µ+Ø¡t
∑
1
√t °"
∏
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where √t was defined earlier. Under assumption (A2), √t is decreasing in it but in-
creasing in d . This means the NFR responds positively to it but negatively to d . When
child mortality falls due to lower prevalence rates, the TFR decline is strong enough to
ensure that NFR falls. In contrast, a decrease in the child mortality rate due to lower
case fatality elicits a weak TFR response and the NFR increases despite fertility falling.
Turn now to the quantity-quality tradeoff. Quality investment in either type of child
is increasing in√t . Thus a reduction in child mortality through lower prevalence raises
quality investments in both healthy and unhealthy children. The opposite is true for
gains in child survival through lower d . A lower d implies that fewer sickly children
succumb and a higher proportion of surviving children are of low quality. Parents have
to devote more time towards raising unhealthy children on whom quality investment
yields low returns.
Child mortality has a different effect on population growth in corner equilibria. For
example, when parents do not invest in either type of child, the NFR responds nega-
tively to it but positively to d unless øu = øh in which case theNFR is unaffected, similar
to Doepke (2005). Lower d shifts the childbearing cost towards unhealthy children who
requiremore attention, lowering the demand for children. In contrast, lower i shifts the
cost towards healthier children and demand rises.
Beyond these, a continued decline in prevalence as it crosses first the threshold i h ,
then i u , has a general equilibrium effect: parents switch from valuing quantity alone
to also valuing child quality. Furthermore, in both interior and corner equilibria, a re-
duction in prevalence extends adult longevity. As parents place a higher weight on their
future consumption, fertility falls further. While the overall effect on fertility depends
on equilibrium type and child morbidity, a reduction in case fatality alone does not
generate a similar effect from adult survival to family size.
3.5 Disease Dynamics
While the prevalence rate it is exogenous to a household’s decisions, it evolves endoge-
nously in the aggregate. A pre-transition or transitional economy with high average
mortality is best viewed as one where infectious diseases are endemic. We use a simple
version of the SIR epidemiological model for this.
Suppose that a fraction µ0 of children who survive from infectious disease remain
infective as adults. The remaining 1°µ0 fraction recover but not from the scarring effect
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of their childhood illness. Suppose also that all newborns are susceptible to infection
and that each of them is “matched” with µ1 > 1 adults, similar to John (1990).11
A proportion µ0pit/(1°dit ) of these adults is infective. Let a be the transmission
rate from a match. Then the number of newborns who contract infections in t + 1 is
It+1 = ºtnt+1Lt+1 where ºt = µa
£
pit/(1°dit )
§
, µ ¥ µ0µ1 > 1 by assumption and each
of the Lt+1 young adults at t +1 has nt+1 children. For high enough prevalence, ºt can
exceed one. Hence we specify that the infection rate it ¥ It/ntLt follows
it+1 = g (it )¥min{º(it ),1}. (11)
Equation (11) always entertains zero prevalence as a steady state whose stability de-
pends on g 0(0) = µap. The product µa is the so-called epidemiological threshold or
basic reproduction ratio, the number of secondary cases per primary case of infection.
We assume that in a pre-transition population
µa > 1 (A4)
whichmeans each infective person infectsmore than one. Under conditions we specify
below this can cause the disease to become endemic over time.
In addition to (A4) when we have µap > 1, the zero steady state is asymptotically
unstable and º(ıˆ) > 1 for ıˆ ¥ 1/[d +µap]. Full prevalence is the only asymptotically
stable steady state, as in Figure 8(a), and the disease is eventually endemic. In other
words, all children at some point in their childhood contract infections.
Maintaining assumption (A4), suppose instead the survival rate is low enough that
µap < 1. This corresponds to Figure 8(b), where an intermediate steady state appears at
i§ = (1°µap)/d that is increasing (decreasing) in the case fatality (survival) rate d (p).
For initial prevalence i0 > i§, infections spread rapidly until full prevalence is reached.
Infections eventually abate, in contrast, for i0 below i§. Even though the basic repro-
duction ratio exceeds one, enough people have to be infective in order for the disease
to reach endemic proportions. Since ıˆ and i§ are decreasing in p, better therapy by rais-
ing (lowering) p (d) makes full prevalence more likely for a given i0. Higher p ensures
11Alternatively, infected people transmit the germs to non-human hosts that then assist in new infec-
tions through disease vectors. For a disease like malaria the matching occurs through mosquitoes that
take bloodmeal from the infective person and, after sporogony, release the parasite into the bloodstream
of an uninfected child. For diarrhea, on the other hand, the disease vector can be food, water or humans
themselves.
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a larger pool of infective agents and faster transmission rates. In contrast, since i§ is
decreasing in µa, improvements in prevention make full prevalence less likely.12
The last case, Figure 8(c), holds when (A4) is overturnedwhich also implies µap < 1.
Zero prevalence is the unique asymptotically stable steady state: the basic reproduction
ratio is too weak to forever sustain infections. This scenario captures post-transition
societies that have eradicated endemic infectious diseases.
4 General Equilibrium
4.1 Factor Prices
In competitive markets, the Cobb-Douglas production technology leads to the familiar
pricing functions for labor and capital, wt = (1°Æ)AkÆt and, Rt =ÆAkÆ°1t respectively.
Here w is the wage rate per efficiency unit of labor, R the rental on capital as well as the
interest factor and kt ¥Kt/Xt the physical-to-human capital ratio.
4.2 Population and Labor Supply
From here onwemake the simplifying assumption that ∑= 0 whichmeans a child’s hu-
man capital is determined by his health history and economic aggregates, not parental
characteristics. This human capital takes one of two values that depend on the average
stock of human capital and the prevalence rate.
Let Gt (x) denote the period-t measure of young adults with human capital below
x. A young adult with human capital xt has n(it ) children of whom pitn(it ) grow up to
be unhealthy adults with xut+1 units of human capital and adult longevity 1+¡u . The
remaining (1° it )n(it ) surviving children grow up healthy with xht+1 units of human
capital and adult longevity 1+¡h . This determines the future working population as
Lt+1 = (1°dit )n(it )
Z1
0
dGt (xt )= (1°dit )n(it )Lt . (12)
The aggregate stock of human capital of Lt workers is Xt =
R1
0 xtdGt (xt ) and human
capital per worker x¯t ¥ Xt/Lt . Using this output per worker is yt = AkÆt x¯t .
12This distinction between the effects of p and µa is somewhat artificial. For pneumonia and pertussis,
for example, antibiotics can reduce the time a person remains contagious. Prevention, however, reduces
prevalence more than treatment by also removing the window of contagion. Our calibration allows for
the possibility that a given intervention has both preventive and curative effects.
18
Suppose worker type is costlessly observed and annuity sellers calibrate their re-
turns to the mortality risk of each group. Healthy workers earn the (gross) return R/¡h
on their saving, unhealthy workers earn the higher return R/¡u . Aggregate saving is
St =æu
Z
{xt :It°1=1}
wtxtdGt (xt )+æh
Z
{xt :It°1=0}
wtxtdGt (xt )
where æu ¥ Ø¡u/(1+Ø¡u +∞)< Ø¡h/(1+Ø¡h +∞µ)¥æh and market clearing is deter-
mined by the usual Kt+1 = St .
4.3 Dynamics
The aggregate stock of human capital is Xt+1 =
£
pit xut+1+ (1° it )xht+1
§
Lt+1. The human
capital of each child type, xht+1 and x
u
t+1, is linear in x¯t where the proportionality func-
tions Ωht and Ωut depend on the prevalence rate according to
Ωht =
8>>><>>>:
∏
h
∫(1°µ)
µ°∫(1°µ)
n
øt°¥it
1°dit °"
oi∫
when 0∑ it < i u ,
∏
h
∫(1°µ)
µ°∫(1°µ)(1°it )/(1°dit )
n
øt
1°dit °"
1°it
1°dit
oi∫
when i u ∑ it < i h ,
∏"∫ when i h ∑ it ∑ 1,
and Ωut = ±∫Ωht in the first case, ∏"∫ in the latter two. The evolution of human capital
per worker can now be parsimoniously represented by
x¯t+1 ¥ Xt+1Lt+1 =
£
pitΩut + (1° it )Ωht
§
x¯t ¥ Ω(it )x¯t (13)
and asset market clearing by
Kt+1 =
£
æuΩut pit°1+æhΩht (1° it°1)
§
(1°Æ)AkÆt x¯t°1 (14)
given K0 > 0 units of capital owned by the initial old generation and the initial distribu-
tionG0 among working households.
Definition. The general equilibrium of this economy consists of sequences of {Kt , x¯t , it }
and cumulative density functions Gt (x) that satisfy equations (11), (13) and (14), given
K0 > 0, i0 > 0 andG0.
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5 Transitions
Since disease prevalence does not depend on economic behavior, equation (11) evolves
independently of equations (13) and (14). The long run trajectory of this economy is
driven by disease dynamics, specifically the vector of parameters (i0,µ,a,p).
First note that steady-state growth of output per worker depends on whether or not
human capital accumulation can be sustained on its own. That requires Ω(it )> 1 in (13)
inwhich case a decrease in the prevalence rate unambiguously raises the rate of human,
and thus, physical capital accumulation. When limt!1 it = 0, the asymptotic growth
factor of human capital andoutput perworker isΩ(0)=∏[∫(1°µ)(øh °")/{µ°∫(1°µ)}]∫.
When limt!1 it = 1, since no child receives quality investment, the long-run growth
factor is Ω(1) = p∏"∫, lower than Ω(0). The saving propensities æh and æu have no ef-
fect on the growth rate, only level effect on the balanced growth path (BGP). Hence two
BGPs are possible and the economy converges to only one of them for a given vector
(i0,µ,a,p).
5.1 Balanced Growth Paths
The first BGP, a Malthusian regime, exists when (A4) holds and infectious disease fa-
talities are high enough that µap < 1 (Figure 8b). For i0 > i§, full prevalence is the
only stationary equilibrium. Along this BGP, fertility remains high and infections ex-
tract a high mortality toll on children. As all children are affected, survivors carry their
morbidity burden in the form of low human capital and high risk of premature death
from non-communicable disease. Low labor income and adult longevity both imply
low rates of investment in physical capital. This BGP exhibits slow (if any) growth in
income per capita of Ω(1)°1 and persistent morbidity.
The second stationary equilibrium exhibits modern economic growth (MEG) and
corresponds to µa < 1 (Figure 8c). Absent any threat of infections, child survival is en-
sured, fertility low and human capital relatively high. This economy is also in a post-
epidemiological transition phase where adult longevity is maximal. High rates of in-
vestment in physical and human capital ensure a high growth rate of Ω(0)°1.
Since the prevalence rate is either at zero or at hundred percent, we can easily com-
pare quantity and quality decisions in the two steady states. We proceed with the as-
sumption, validated later by our calibration, that i u < 1 and i h > 0 so that eu(i = 1)= 0
and eh(i = 0)> 0. Recall that the average fertility cost ¬ is decreasing in the prevalence
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rate. In the Malthusian BGP, this cost takes the lowest possible value ¬L = (1°d)øu , in
theMEG BGP the highest possible value ¬H = µ (øh °")/[µ°∫(1°µ)]. It follows that the
TFR in the Malthusian BGP takes the high value nH and in the MEG BGP a lower value
nL where
nH = ∞µ1+∞µ+¡u
∑
1
(1°d)øu
∏
, nL = ∞µ1+∞µ+¡h
µ
µ°∫(1°µ)
µ
∂∑
1
øh °"
∏
.
The fertility differential across these steady-state values is driven by differences in these
parameters (d ,øu ,øh ,±,¡u ,¡h). The first four parameters are related to the cost of fer-
tility, the last two determine parental willingness to substitute between personal con-
sumption and altruistic behavior. The corresponding net fertility rates in the two steady
states are
nˆH = (1°d)nH , nˆL = nL
and human capital investment per child
eu = 0, eh = ∫(1°µ)
µ°∫(1°µ)
µ
øh ° µ"
∫(1°µ)
∂
respectively, since all children are of homogeneous quality in either BGP.
5.2 Transitions Then
Start with assumption (A4) which is more likely when µa is relatively high. Prior to
the public health and medical innovations of mid-to-late nineteenth century England,
fatalities from childhood infections would have been high too. Such a pre-transition
economy corresponds to Figure 8(b) with i0 > i§.
John Snow’s work in identifying the cause of London’s 1854 cholera epidemic, the
Public Health Acts of 1848 and 1875 and the commissioning of London’s integrated
sewerage system in 1865 paved the way for England’s conquest of infectious disease
(Szreter, 1988). Improved sanitation and water management led to cleaner water sup-
plies, food safety and effective sewage disposal. Supervision of water, food and pasteur-
ization of milk drastically cut down the incidence of cholera, dysentry, typhoid, hook-
worm, diarrhea, measles and whooping cough. Immunization programs for dipthe-
ria, smallpox, tuberculosis and whooping cough complemented these public health re-
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forms 1880 onwards. Between 1861 and 1900, over 55% of England’s mortality decline
was accounted for by the control of five diseases – smallpox, scarlet fever, whooping
cough, diarrhea and typhoid – all of which affected children in large numbers (Hinde,
2003).13
These preventive breakthroughs are akin to a reduction in µa. When the reduction
is large enough to overturn (A4), zero becomes the unique asymptotically stable steady
state as in Figure 8(c). But innovations do not have to be so drastic as to eliminate i§.
Modest continuing improvements in µa keep raising this threshold prevalence rate: an
economy converging towards full prevalence eventually falls below this threshold. At
that point, the transmission rate has been brought under sufficient control that it is
possible to gradually eradicate endemic infectious diseases. Falling infectious disease
mortality and morbidity usher in a fertility transition. Both TFR and NFR decline, as
parents substitute towards quality investment and late-life survival improves. Rapid
demographic and disease transitions, in turn, drive the economy towards MEG.
5.3 Transitions Now
Twentieth century reductions in child mortality in developing countries have been fa-
cilitated by the transfer of public health innovations and medical technology, notably
vaccines and antibiotics, from the West. In some cases, such as smallpox and polio,
these transfers have wiped out major killers of children. Yet progress towards eradica-
tion has been uneven and nowhere is this more apparent than in SSA. Despite a half-
century of falling child mortality at a rate comparable to England & Wales, prevalence
rates for SSA’s major killer diseases remain high.
This is due to two reasons: deficiencies of best practice interventions andmoribund
public health systems. Consider malaria and diarrhea which together accounted for
34% of child deaths in Africa in 2005 (WHO). Eradication campaigns during the 1960-
70s reduced malarial mortality by 18%, much of it due to better therapy (chloroquine),
some due to vector control (DDT). Since the 1980s the disease has resurged to pre-1960
levels from chloroquine resistance and vectorial resistance to DDT. It now accounts for
18% of child deaths in SSA, as it did prior to 1960.14 Diarrheal mortality, on the other
hand, has fallen in Africa by about 10.5%during 1990-2000. Most of this reduction is not
13Therapy played a minor role. Antibiotics for scarlet fever, for instance, were to be invented later.
14It is conceivable that this resurgence partly accounts for the drop in adult stature in the 1980s directly,
and indirectly from co-morbidity with other diseases.
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due to lower incidence but from the spread of an effective treatment (ORT) which re-
duced diarrheal mortality by 9% (Ewbank and Gribble, 1993; Boschi-Pinto et al., 2006).
Since as much as 88% of diarrheal deaths in Africa is water and sanitation related, this
reflects an institutional failure to provide adequate sanitation and potable water, in-
terventions that so radically transformed England’s disease landscape (Guerrant et al.,
2003).
Successful disease prevention comes from both private and public interventions.
Private health investment exhibits positive externalities, so without public intervention
there is too little investment. Effective public intervention, on the other hand, requires
credible macroeconomic policies and institutions that are costlier to implement than
importing (subsidized) therapeutic interventions. Low levels of public health funding
in SSA have shifted focus to a handful of cost effective treatments. In some cases a
curative strategy has been prioritized over prevention (Ewbank and Gribble, 1993; Sahn
and Bernier, 1995).
In terms of our theory, thismeans childmortality has fallen in SSA through a combi-
nation of better cures (lower d) and weaker transmission (lower µa), the first of which
would have had a weak effect on fertility choice and human capital investment. We
proceed to examine the quantitative significance of such a mortality transition.
6 Quantitative Experiments
We start by calibrating the model and then present three experiments. The first experi-
ment simulates England’s transitions and compares them to slower counterfactuals rel-
evant for developing countries generally. The second is specifically tailored to account
for transitions in SSA. Finally we show that child mortality improvements, which have
contributed globally to improvements in life expectancy at birth, have little effect on
economic growth unless accompanied by improvements in morbidity.
6.1 Parameter Values
Table 1 reports benchmark parameter values. Childhood is assumed to last 15 years
and each period of adulthood potentially 30 years long. Maximum longevity is then 75
years, commensurate with life expectancy in post-transitionUK in the 1950s and 1960s.
A pre-transition economy in ourmodel is at full prevalence. Assumingpre-transition
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Preference Technology Disease Ecology
µ = 0.36 ∏= 2.85 µ= 1.5
Ø= (0.99)120 = 0.30 "= 0.12 a = 0.87
¡h = 1 ∫= 0.48 d = 0.28
¡u = 0.46 A = 10 ±= 0.85
∞= 1.13 Æ= 1/3
øu = øu = 0.15
Table 1: Parameter Values
UK (1860°69) is close to this, we start at i0 = 1. In the model parents implicitly choose
quality investment in surviving children after the first 5 years of life. The value for d
is picked to be 0.28 so that i0d matches the child mortality rate of 0.28 (probability of
dying between ages 0-5) in the UK between 1860° 69 (mortality.org).15 Normalizing
¡h = 1, we set ¡u = 0.46 to match life expectancy (LE) at age 15 of 43.8 in the UK during
the same period (mortality.org). In the absence of information on the differential cost
of raising sickly children, child rearing costs (øh ,øu) are both set equal to 0.15 (Have-
man and Wolf, 1995) which satisfies (A2). Since we do not have resource cost of raising
children this caps the fertility of a household of two parents at a little above 13. For the
quantity-quality tradeoff we set µ to 0.36 which, given the value for ∫ reported in Table
1, satisfies (A1). Consistent with data for theUK, we set ∞= 1.13 such that pre-transition
TFR is 4.9 children per woman.
For the human capital technology, since externalities can yield growth in human
capital even in the absence of quality investment when ∑ = 1, we set " so that there is
no growth in human capital (and output) per worker in this scenario. We set ∏ = 2.85
so that post-transition economic growth converges to 1% annual growth of GDP per
worker, consistent with data for the UK (Broadberry and Klein, 2011). Then ∫ = 0.48
implies post-transition TFR reaches replacement level. For the aggregate technology, Æ
is set to 1/3 and A normalized to 10.
Since the effects of µ and a are not separately identified in the model, we arbitrarily
set µ = 1.5 which requires a > 0.67 for µa > 1. We set a = 0.87 which ensures that (A4)
is satisfied and Figure 8(b) applies (pµa < 1). The morbidity parameter ± is calibrated
fromevidence on labor earnings. Recall thatmalaria is themain cause of childmortality
15Human Mortality Database, University of California, Berkeley (USA), and Max Planck Institute for
Demographic Research (Germany). Downloaded from www.mortality.org in July, 2011.
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in sub-Saharan Africa. Cutler et al. (2007) estimate that moving from the most to least
malarious district in India raised income of male workers by 3-13% though no effect on
educational attainment is observed. Bleakley (2010), on the other hand, finds malaria
eradication affected both school attainment and earnings in Brazil, Colombia, Mexico
and the US. According to his estimates, income between the least and most malarious
regions differed by 12-40%, persistent malarial morbidity lowering income by as much
as 50%. Arguably early-life exposure tomalaria has a greater health effect in Africa than
elsewhere. On the other hand, ourmodel does not distinguish between chronically and
occasionally infected children and morbidity from other infections like diarrhea could
well be smaller. Hence ± is best viewed as the average morbidity effect on all children
who have survived various types of childhood infections. We set its value to 0.85. The
implied earnings gap of 8% between healthy and unhealthy workers matches the mid-
point estimate of Cutler et al.16
6.2 The Historical Transition
Starting with an initial parameter vector (a0,d0) = (0.87,0.28) for an economy in the
Malthusian regime, consider two scenarios. In the first one relevant for developed
countries (DC) that underwent demographic transitions in the nineteenth century, the
economy experiences an exogenous reduction in child mortality as the prevalence rate
falls. Maintaining the value of d , a large decline in a from a0 = 0.87 to a0 = 0.37 pushes
i§ above 1 and a transition towards full eradication begins as the economy switches
from panel (b) to (c) in Figure 8.
The second scenario broadly replicates those less developed countries (LDC) where
child mortality fell in the twentieth century from a combination of lower prevalence
and better cures. These interventions could be different types of preventive and cura-
tive interventions, or those that are primarily curative but also have an indirect effect in
lowering prevalence. We choose a new set of values (a1,d1) so that the immediate im-
provement in child survival is equal to that in the first scenario. We lower a to a1 = 0.58,
just enough to eliminate the full prevalence steady state. The residual improvement
in child survival is absorbed by the fatality rate falling to d1 = 0.18. The combined ef-
fect also starts a transition towards full eradication, but at a slower pace. We start both
economies (DC and LDC) with (x0,k0)= (1,0.17), the steady-state values of human and
16In pre-transition, childhood infections matter only for late-life mortality, ± is irrelevant.
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physical capital per worker in the pre-transition economy. Figure 9 illustrates the de-
mographic, epidemiological and economic responses.
The English transition began around 1872 and by 1950 child survival had improved
to 96.5%, LE at age 15 to 57 years, and the TFR had fallen to 2.1. The simulated DC
transition matches these trends closely. Within three generations (90 years), child sur-
vival is 96.7%, LE at age 15 is 56.6 years and TFR 2.1 per woman, the latter specifically
targeted in our calibration. In contrast, the LDC transition takes almost three times as
long. Due to higher childhood morbidity in the first few generations, TFR is generally
higher resulting in a population explosion. During the first forty years of the UK and
SSA transitions, CMR fell by similar magnitudes (about 46%) but TFR responded more
strongly in theUK, with an elasticity of 0.82 relative to 0.46 in SSA. By construction child
mortality falls by the samemagnitude initially in the two cases reported in Figure 9. The
TFR response is stronger in the DC transition: its elasticity with respect to CMR in the
first period is 0.64 relative to 0.34 for the LDC transition. While this under-predicts the
fertility transition – presumably other factors also facilitated the transition – the relative
speed of the two regions is comparable to the data. Due to the slower transition, worker
productivity and GDP per worker are permanently lower in the LDC scenario.17
Noninfectious disease mortality among the elderly fluctuated around 40% in the
UK prior to the transition, began to decline in 1900, about one generation after infec-
tious disease mortality started to fall, and dropped to 9% by 1980 (Arora, 2005). Our
simulations slightly over-predict late-life mortality for the DC transition. The noninfec-
tiousmortality rate begins at 54% of the elderly and, after lagging the infectious disease
mortality decline as in the data, falls to 11% in four generations or 120 years. In the LDC
scenario, in contrast, noninfectiousmortality falls only to 38% four generations into the
transition, about four times higher than the DC scenario similar to the facts outlined in
section 2.2.
The nature of the LDC mortality transition extracts a cost relative to the DC transi-
tion. Since the prevalence rate initially falls by less, childhood morbidity and late-life
mortality remain high several generations into the transition. This mutes the fertility
response through the quantity-quality and adult longevity margins.
17The simulated elasticity gap is larger than that for other developing regions. Outside SSA, the elastic-
ity ranges from 0.69 for MENA to 0.81 for East Asia. Child mortality fell, however, by a larger magnitude
in these regions relative to SSA or the UK during comparable periods.
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6.3 The Transition in Sub-Saharan Africa
Beginning in the 1960s, child mortality improved in SSA due to a combination of more
widely available antibiotics, the use of DDT in malaria eradication efforts and the es-
tablishment of the WHO which facilitated technology transfer and public health cam-
paigns. Later in the 1980s child vaccination further lowered mortality. The LDC experi-
ment above was inspired by this combination of prevalence- and therapy-based efforts.
But two features distinguish SSA. First, its pre-transition (1950-60) CMR was actually
lower than the UK’s (1850-70). Pre-transition TFR, on the other hand, was significantly
higher. It is plausible that even if SSA had benefited from a prevalence-only mortality
reduction, its transition to replacement fertility would have been slow. To identify how
much slower SSA’s experience has been relative to such a prevalence-only scenario, we
recalibrate the model to match SSA’s pre-transition levels of CMR and TFR and its ob-
served fertility transition since the 1960s.
Compared to the UK benchmark, the parameter ∞ is adjusted to 2.69 to match the
higher pre-transition TFR in SSA which fluctuated around 6.6-6.7 during 1950-1960.
We then set ∫ = 0.30 and µ = 0.25 to maintain post-transition fertility at replacement
level. We lower the value of ± to 0.75 (earnings gap of 8% as before) in order to match
the slower rate of transition in SSA during 1960 - 2010 relative to the UK. In fact, SSA’s
TFR barely moved during the first thirty years of its CMR decline. The new values of ∫
and µ ensure that quality investment is nil and fertility relatively high during the first
generation of the transition. The value for d is picked to be 0.25 so that i0d matches
the mortality rate for children under age 5 in SSA in 1960 (World Bank). Remaining
parameter values are same as in Table 1.
We start with the initial configuration (a0,d0) = (0.87,0.25) for the pre-transition
economy. To simulate the SSA transition, child mortality falls from a combination of
exogenous reduction in prevalence and case fatalities. Specifically, a falls from 0.87
to 0.52 so that the economy can start transitioning towards zero prevalence while d
falls from 0.25 to 0.2. Together these changes replicate the two-period (1950/60°2010)
changes in CMR and TFR observed for SSA: two generations after the mortality shock,
TFR falls to just under 5 children per woman (Figure 10), similar to what we observe in
the data (Figure 2).
The alternative scenario in Figure 10 shows what would have happened had the
initial mortality decline been solely from lower prevalence. Holding the case fatality
rate constant at 0.25, a declines from 0.87 to 0.41 to match the initial drop in CMR for
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SSA.Not surprisingly the demographic transitionwould have progressed further by now
with fertility significantly lower at 3.2, laggingMENA and South Asia by about a decade.
At its current pace, SSA will reach that level by 2040.
Life expectancy at birth rose in SSA from 41 to 54 years during 1960-2010 (World
Development Indicators), some of the progress undone by the HIV crisis since the late
1980s. In contrast life expectancy at age 15 changed little in the decades leading up to
the HIV crisis, from 40.2 years in 1975 to 41.2 years in 1980 to 40.6 years in 1990, falling
to 38.3 years by 2000 due to the AIDS epidemic. The third panel of Figure 10 shows
how life expectancymight have improvedwith child survival in the absence of the AIDS
epidemic, where ¡u has been chosen to match LE at age 15 in SSA in 1975.18
6.4 The Role of Morbidity
Several effects are at work in these experiments: how childhood morbidity affects hu-
man capital, how it affects adult mortality, and the trajectory of child mortality from a
falling prevalence rate.
To clearly identify the role of morbidity, we construct “impulse responses”. Starting
from full disease prevalence and 28% case fatalities (CMR of 28% as in the UK experi-
ment), we hold the prevalence rate at a level where an exogenous reduction in i does
not tip the economy towards zero prevalence. This switches off the dynamic response
due to changing prevalence. We then compare the growth effects of a reduction in child
mortality due to an exogenous reduction in case fatalities from 28% to 18% versus the
same decrease when the prevalence rate falls to 64%. In the two cases, the initial in-
crease in life expectancy at birth is identical.
Weplot the annualized growth rate ofGDPper capita for the i -decline andd-decline
scenarios when ± = 0.85 (UK experiment) and ± = 1 (no scarring effect). To maintain
positive human capital investment in each of the following experiments, µ is lowered
to 0.35. Parameter values are otherwise identical to the UK experiment. The initial
increase in life expectancy at birth is 1.5 years, from 54.6 to 56.1. In Figure 11 economic
growth is permanently faster in the i -decline scenario when ±< 1 (left panel), because
the NFR declines and human capital investment in each child increases, while in the d-
decline scenario these remain unchanged. For the ± = 1 case, the difference in growth
18While the transition began earlier in SSA, data availability restricts us to 1975. If life expectancy at 15
responds to CMR with a lag, then it would have been similar between 1950 and 1975.
28
rates between the i -decline and d-decline scenarios is temporary and results from old-
age mortality differences. Since ¡u < ¡h = 1, children who suffer from infections grow
up predisposed towards non-infectious disease in old age. These individuals save less
of their income and have more children, thereby slowing human and physical capital
accumulation.
To isolate the effect of childhood morbidity we next set ¡u = ¡h = 1. Childhood
infections now affect fertility through the quantity-quality margin alone. Initially life
expectancy at birth rises by 1.5 years, from 70.8 to 72.3. As in the previous case, a per-
manent growth gap opens up between the two cases when ±< 1 (Figure 11, right panel).
If ±= 1, all childrenwhether infected or not grow up to be healthy, so fertility, quality in-
vestment and saving decisions are identical in the two economies. The long-run growth
effects are identical in the two panels because only childhoodmorbidity affects human
capital accumulation, the engine of growth in this model. Of course, as we have shown
earlier, if both economies were to converge to zero prevalence in the long run, eventu-
ally growth rates will converge but income levels will not.19 In fact for ±< 1 the resulting
income gapwould be even greater becausemorbidity persists in the d-decline scenario.
When i = 1, all surviving children are unhealthy and a decline in d does not change
this. When i < 1, some surviving children are healthy while others are unhealthy, so a
decline in d raises the proportion of unhealthy children relative to healthy ones. When
i = 1 human capital investment per child and the NFR are unaffected by changes in
d , but if initial i < 1, then a reduction in the case fatality rate generates an increase in
the NFR and a decrease in human capital investment as long as ±< 1. We illustrate this
scenario by starting with i = 0.9 and d = 0.31 so that initial CMR = 28%, the same as
before. We then compare the growth effects when case fatalities decline from 31% to
20% versus the same decrease in child mortality from the prevalence falling from 90%
to 58%. CMR falls from 28% to 18% in all of the scenarios in Figure 11, but economic
growth decreases initially only in the d-decline scenario when initial i < 1. For ± = 1
growth dips initially with the d-decline only if ¡u < ¡h due to the longevity effect. For
±< 1 the longevity effect contributes to the dip in growth when ¡u < ¡h , while human
capital investment declines with a fall in d regardless of the values for ¡u and ¡h .
We conclude that when childhood infections have a scarring effect, a reduction
in child mortality (or increase in life expectancy at birth) does not increase economic
19In Figure 11, a lagged response occurs because lower morbidity translates into higher physical and
human capital among the following generation of working-age adults.
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growth unless childhood morbidity also falls, as in the i -decline scenario. Indeed, the
d-decline scenario shows that growth may temporarily fall when reductions in child
mortality dilute average child quality and increase fertility.
7 Conclusion
This paper shows that themorbidity effect of infectious disease is an important element
of demographic and epidemiological changes in the long run. We constructed a dynas-
tic model of endogenous mortality and fertility where childhood infections depreciate
child quality and predispose people towards non-infectious disease in late life. A cali-
brated version of the model is able to explain why sub-Saharan Africa’s mortality tran-
sition has not generated the kind of fertility, epidemiological and economic responses
that we have seen historically or in other developing regions.
Mortality, particularly among children, has been widely used as a parsimonious
metric of economic development. A notable implication of our analysis is that child
mortality (or life expectancy at birth) is a weak proxy of a population’s underlying health
since mortality and morbidity do not always move in the same direction, a point made
earlier by Murray and Chen (1992). Higher life expectancy at birth facilitates a fertil-
ity transition and economic development only when accompanied by lower childhood
morbidity and adult mortality.
In a promising development, some African countries have recently reduced infant
and child mortality through prevalence efforts. Kenya’s infant mortality rate fell from
8.1 to 6.0%between 2003 and 2008-09 drivenwholly by reductions in postneonatalmor-
tality. This was made possible by new public health efforts targeting the transmission
of infectious diseases, for instance increased usage of insecticide-sprayed bednets and
better access to clean water and sanitation (Demombynes and Trommlerova, 2012). In
our view, replicating this experience across the continent would facilitate sub-Saharan
Africa’s demographic and epidemiological transitions and contribute to its economic
development.
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